| Jason Flamiatos, MD, MPH | |
|
1247 Ne Medical Center Dr Ste C, Bend, OR 97701-3786 | |
| (541) 322-5753 | |
| (541) 278-8368 |
| Full Name | Jason Flamiatos |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1247 Ne Medical Center Dr Ste C, Bend, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942633805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 71864-20 (Wisconsin) | Primary |
| Entity Name | Yavapai Community Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902897820 PECOS PAC ID: 6608777024 Enrollment ID: O20040119000405 |
News Archive
Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.
Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.
Health Net, Inc. is providing the option of continuing coverage for adult dependents up to age 26 who are currently enrolled on their parents' health care policies.
Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of illness. However, the prevalence of eye, musculoskeletal, and neurological complications was greater among the individuals who survived EVD.
Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Fraxel re:store(R) Dual system, providing superior results for large body areas during a single treatment. Prior to the non-ablative Fraxel re:store Dual system, laser skin resurfacing procedures were largely limited to the face.
› Verified 9 days ago
| Entity Name | Yavapai Regional Medical Center Physician Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255582003 PECOS PAC ID: 5294898987 Enrollment ID: O20090106000798 |
News Archive
Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.
Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.
Health Net, Inc. is providing the option of continuing coverage for adult dependents up to age 26 who are currently enrolled on their parents' health care policies.
Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of illness. However, the prevalence of eye, musculoskeletal, and neurological complications was greater among the individuals who survived EVD.
Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Fraxel re:store(R) Dual system, providing superior results for large body areas during a single treatment. Prior to the non-ablative Fraxel re:store Dual system, laser skin resurfacing procedures were largely limited to the face.
› Verified 9 days ago
| Entity Name | Hrmc, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003139387 PECOS PAC ID: 3072641265 Enrollment ID: O20100508000148 |
News Archive
Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.
Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.
Health Net, Inc. is providing the option of continuing coverage for adult dependents up to age 26 who are currently enrolled on their parents' health care policies.
Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of illness. However, the prevalence of eye, musculoskeletal, and neurological complications was greater among the individuals who survived EVD.
Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Fraxel re:store(R) Dual system, providing superior results for large body areas during a single treatment. Prior to the non-ablative Fraxel re:store Dual system, laser skin resurfacing procedures were largely limited to the face.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Flamiatos, MD, MPH Po Box 1517, Pendleton, OR 97801-0410 Ph: (877) 708-1119 | Jason Flamiatos, MD, MPH 1247 Ne Medical Center Dr Ste C, Bend, OR 97701-3786 Ph: (541) 322-5753 |
News Archive
Researchers at Biolinker, a biotech startup based in São Paulo, Brazil, are developing a low-cost high-performance COVID-19 diagnostic test using only locally sourced inputs.
Genentech, a member of the Roche Group, announced today that the second of two Phase III trials evaluating Lucentis in patients with diabetic macular edema met its primary endpoint.
Health Net, Inc. is providing the option of continuing coverage for adult dependents up to age 26 who are currently enrolled on their parents' health care policies.
Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of illness. However, the prevalence of eye, musculoskeletal, and neurological complications was greater among the individuals who survived EVD.
Solta Medical, Inc. (Nasdaq: SLTM) today announced the launch of its new Fraxel re:store(R) Dual system, providing superior results for large body areas during a single treatment. Prior to the non-ablative Fraxel re:store Dual system, laser skin resurfacing procedures were largely limited to the face.
› Verified 9 days ago
Dr. Matt S Ashley, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 | |
Dr. Daniel Levi Willis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701 Phone: 541-382-6447 | |
Andrew David Neeb, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 431 Ne Revere Ave Ste 200, Bend, OR 97701 Phone: 541-508-7973 Fax: 541-508-7968 | |
Hagop Sarkissian, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct Ste 101, Bend, OR 97701 Phone: 541-382-6447 | |
Dr. Meredith Rae Baker, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 | |
Dr. Michel Adeodat Boileau, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 | |
Dr. Jack Alan Brewer, MD Urology Medicare: Medicare Enrolled Practice Location: 2090 Ne Wyatt Ct, Suite 101, Bend, OR 97701 Phone: 541-382-6447 Fax: 541-330-7413 |